B12 Ankermann 1000 µg drag 1 mg 100 pce

7680687960021 CH-68796 B03BA01 06.07.2.

No images available

Details

Product number
6879601
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
cyanocobalaminum 1 mg, lactosum monohydricum 258.7 mg, povidonum K 30, acidum stearicum, carmellosum natricum conexum, Überzug: acaciae gummi, calcii carbonas, macrogolglyceroli hydroxystearas 0.07 mg, macrogolum 6000, saccharum 58.87 mg, talcum, titanii dioxidum, kaolinum ponderosum, natrii laurilsulfas, cera montanglycoli, hypromellosum, hydroxypropylcellulosum, acidum stearicum, triglycerida media, pro compresso obducto corresp. natrium 0.52 mg.

Articles (1)

B12 Ankermann 1000 μg, überzogene Tabletten
überzogene Tabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/06/2026
Patient information leaflet
Français
12/06/2026
Patient information leaflet
Italien
12/06/2026
Professional SmPC
Allemand
17/03/2026
Professional SmPC
Français
17/03/2026
Professional SmPC
Italien
17/03/2026

Detailed composition

Substance Quantity Type Category
cyanocobalaminum
1.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
258.7 MG Substance HBESI
povidonum K 30
- Substance HNIDK
acidum stearicum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
acaciae gummi
- Substance HNIDK
calcii carbonas
- Substance HNIDK
macrogolglyceroli hydroxystearas
0.07 MG Substance HBESI
macrogolum 6000
- Substance HNIDK
saccharum
58.87 MG Substance HBESI
talcum
- Substance HNIDK
titanii dioxidum
- Substance HNIDK
kaolinum ponderosum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
cera montanglycoli
- Substance HNIDK
hypromellosum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
acidum stearicum
- Substance HNIDK
triglycerida media
- Substance HNIDK
natrium
0.52 MG Substance HBESI

Reimbursement information

Public price
CHF 37.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

Biomed AG

8600 Dübendorf

Authorization information

Swissmedic authorization number
68796
Drug name
B12 Ankermann, überzogene Tabletten
Galenic form
UEBT
ATC Code
B03BA01
Authorization status
Z
Dispensation category
D
First authorization
15/01/2024
Authorization expiration date
14/01/2029
IT number
06.07.2.
Domain
Human medicine
Field of application
Therapie eines Vitamin B12-Mangels

Packaging details

Description (FR)
B12 Ankermann 1000 µg drag 1 mg 100 pce
Description (DE)
B12 Ankermann 1000 µg Drag 1 mg 100 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other packaging sizes

B12 Ankermann 1000 µg drag 1 mg 50 pce
50 TABL
View
B12 Ankermann 1000 µg drag 1 mg 10 pce
10 TABL
View
Buy us a coffee Explore the data